Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell TransplantationAlex F. Herrera, Philippe Armand, Matthew Mei et al.|Journal of Clinical Oncology|2016Cited by 187
CD84 as a therapeutic target for breaking immune tolerance in triple-negative breast cancerStav Rabani, Idit Shachar, Keren David et al.|Cell Reports|2024Cited by 12